Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

Vascular Ehlers–Danlos syndrome (vEDS) is a rare autosomal dominant connective tissue
disease resulting from pathogenic variants in the collagen type III alpha 1 chain (COL3A1) …

Glioblastoma stem cells (GSCs) are cells with a self-renewal ability and capacity to initiate
tumors upon serial transplantation that have been linked to tumor cell heterogeneity. Most …

The epidermal growth factor receptor (EGFR) is the most frequently altered gene in
glioblastoma (GBM), which plays an important role in tumor development and anti-tumor …

Simple Summary Aiming to discover potential treatments for GBM, this review connects
emerging research on the roles of neurotransmitters in the normal neural and the GBM …

Background Glioblastoma (GBM) is considered the most malignant and devastating
intracranial tumor without effective treatment. Autophagy, apoptosis, and necrosis, three …

Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of malignant
prostate cancer for which there is no effective treatment. Although protein kinases are the …

Glioblastoma multiforme (GBM) is the most common form of malignant brain tumor, with poor
prognosis; the efficacy of current standard therapy for GBM remains unsatisfactory …

The protein kinase C (PKC) family plays important regulatory roles in numerous cellular
processes. Saccharomyces cerevisiae contains a single PKC, Pkc1, whereas in mammals …

This case-control study explored compositions of gut microbiome in recurrent malignant
gliomas patients who had received bevacizumab and Temozolomide combination treatment …